Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.
Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.
复制标题
DOI:
10.1016/j.clim.2010.12.010
复制
发表时间:
2011-08
期刊:
影响因子:
--
通讯作者:
Richter J
中科院分区:
文献类型:
--
作者:
Dhodapkar MV;Richter J
Multiple myeloma is a hematologic malignancy characterized by growth of malignant plasma cells in the bone marrow. Tumor cells in myeloma express CD1d and are sensitive to lysis by CD1d restricted natural killer T (NKT) cells. Here we discuss recent studies to harness the properties of these cells in the context of human myeloma. In spite of large body of preclinical data, attempts to fully harness the properties of these cells in the clinic are in early stages. Early phase clinical studies document the capacity of human monocyte-derived dendritic cells to expand NKT cells in vivo in myeloma patients. These results have set the stage for ongoing studies combining NKT activation with immune-modulatory drugs. Lessons learnt from these studies may inform the optimal application of human NKT based therapies in other settings as well.
登录
查看更多内容
影响因子:
2.2
作者:
Fujii, S;Shimizu, K;Dhodapkar, MV
通讯作者:
Dhodapkar, MV
影响因子:
11.4
作者:
Chan, A. C.;Neeson, P.;Berzins, S. P.
通讯作者:
Berzins, S. P.
DOI:
10.1073/pnas.0802968105
发表时间:
2008-06-17
影响因子:
11.1
作者:
Barral, Patricia;Eckl-Dorna, Julia;Batista, Facundo D.
通讯作者:
Batista, Facundo D.
DOI:
10.1084/jem.20042592
发表时间:
2005-05-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Chang DH;Osman K;Connolly J;Kukreja A;Krasovsky J;Pack M;Hutchinson A;Geller M;Liu N;Annable R;Shay J;Kirchhoff K;Nishi N;Ando Y;Hayashi K;Hassoun H;Steinman RM;Dhodapkar MV
通讯作者:
Dhodapkar MV
影响因子:
30.5
作者:
Fujii, S;Shimizu, K;Steinman, RM
通讯作者:
Steinman, RM